Literature DB >> 18775985

Molecular determinants of matrix metalloproteinase-12 covalent modification by a photoaffinity probe: insights into activity-based probe development and conformational variability of matrix metalloproteinases.

Anne-Sophie Dabert-Gay1, Bertrand Czarny, Laurent Devel, Fabrice Beau, Evelyne Lajeunesse, Sarah Bregant, Robert Thai, Athanasios Yiotakis, Vincent Dive.   

Abstract

Mass spectroscopy, microsequencing, and site-directed mutagenesis studies have been performed to identify in human matrix metalloelastase (hMMP-12) residues covalently modified by a photoaffinity probe, previously shown to be able to covalently label specifically the active site of matrix metalloproteinases (MMPs). Results obtained led us to conclude that photoactivation of this probe in complex with hMMP-12 affects a single residue in human MMP-12, Lys(241), through covalent modification of its side chain epsilon NH(2) group. Because x-ray and NMR studies of hMMP-12 indicate that Lys(241) side chain is highly flexible, our data reveal the existence of particular Lys(241) side-chain conformation in which the epsilon NH(2) group points toward the photolabile group of the probe, an event explaining the high levels of cross-linking yield between hMMP-12 and the probe. Lys(241) is not conserved in MMPs, thus differences in cross-linking yields observed with this probe between MMP members may be linked to the residue variability observed at position 241 in this family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775985      PMCID: PMC2662175          DOI: 10.1074/jbc.M805795200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  Proteomic profiling of metalloprotease activities with cocktails of active-site probes.

Authors:  Stephan A Sieber; Sherry Niessen; Heather S Hoover; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2006-03-26       Impact factor: 15.040

Review 4.  Matrix metalloproteinases as valid clinical targets.

Authors:  Barbara Fingleton
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 5.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 6.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 7.  Structural features of a superfamily of zinc-endopeptidases: the metzincins.

Authors:  W Stöcker; W Bode
Journal:  Curr Opin Struct Biol       Date:  1995-06       Impact factor: 6.809

8.  Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.

Authors:  H Nar; K Werle; M M Bauer; H Dollinger; B Jung
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

9.  Lifetimes and reactivities of some 1,2-didehydroazepines commonly used in photoaffinity labeling experiments in aqueous solutions.

Authors:  Mary S Rizk; Xiaofeng Shi; Matthew S Platz
Journal:  Biochemistry       Date:  2006-01-17       Impact factor: 3.162

Review 10.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

View more
  6 in total

Review 1.  The role of targeted chemical proteomics in pharmacology.

Authors:  Chris W Sutton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.

Authors:  Laurent Devel; Sandra Garcia; Bertrand Czarny; Fabrice Beau; Evelyne LaJeunesse; Laura Vera; Dimitris Georgiadis; Enrico Stura; Vincent Dive
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

3.  Sizzled is unique among secreted frizzled-related proteins for its ability to specifically inhibit bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases.

Authors:  Cécile Bijakowski; Sandrine Vadon-Le Goff; Frédéric Delolme; Jean-Marie Bourhis; Pascaline Lécorché; Florence Ruggiero; Christoph Becker-Pauly; Irene Yiallouros; Walter Stöcker; Vincent Dive; David J S Hulmes; Catherine Moali
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

4.  Detection of endogenous matrix metalloprotease-12 active form with a novel broad spectrum activity-based probe.

Authors:  Catherine Nury; Sarah Bregant; Bertrand Czarny; Fannely Berthon; Evelyne Cassar-Lajeunesse; Vincent Dive
Journal:  J Biol Chem       Date:  2012-12-27       Impact factor: 5.157

Review 5.  Chemical biology for understanding matrix metalloproteinase function.

Authors:  Anna Knapinska; Gregg B Fields
Journal:  Chembiochem       Date:  2012-08-30       Impact factor: 3.164

6.  Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

Authors:  Laurent Devel; Fabrice Beau; Mehdi Amoura; Laura Vera; Evelyne Cassar-Lajeunesse; Sandra Garcia; Bertrand Czarny; Enrico A Stura; Vincent Dive
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.